London, England, United Kingdom The main department of described Corporate Investor is located in the London. The company was established in Europe in United Kingdom.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the ConvergInce Holdings, startups are often financed by Oxford Capital Partners, Capricorn Venture Partners, Morningside Group. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Oxford Capital Partners, Capricorn Venture Partners. In the next rounds fund is usually obtained by Tennenbaum Capital Partners, Swire Pacific, Sofinnova Partners.
Among the various public portfolio startups of the fund, we may underline Green Biologics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Chemical Engineering, Chemical.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2013.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Amesten Capital | - |
| Center of Aging and Brain Health Innovation | Canada, Ontario, Toronto |
| Crossventures | Germany, Köln, Nordrhein-Westfalen |
| EMINDSOFT | Beijing, China, Haidian |
| FleetBoston Financial Group | Boston, Massachusetts, United States |
| GAUSS Japan | Japan, Kanagawa Prefecture, Kawasaki |
| Gladstone Capital | Mclean, United States, Virginia |
| Hambro Perks Ltd. | England, London, United Kingdom |
| Hard Money Collective | - |
| IAC | New York, New York, United States |
| Ikigai Asset Management | California, Marina Del Rey, United States |
| Investment Group of Santa Barbara | California, Santa Barbara, United States |
| Kaplan Ventures | Florida, Miami, United States |
| Livzon Mabpharm | China, Guangdong, Zhuhai |
| Mitsui Sumitomo Insurance Company | Chiyoda, Japan |
| Nobska Point Capital | Boston, Massachusetts, United States |
| TerraLab Ventures | Hamada, Japan, Shimane Prefecture |
| TIE Toronto | Canada, Ontario, Toronto |
| Unilumin Group | China, Guangdong, Shenzhen |
| Valor Ventures | Atlanta, Georgia, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Green Biologics | $42M | 21 Jan 2015 | England | ||
Green Biologics | $21M | 02 Dec 2013 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Green Biologics | $42M | 21 Jan 2015 | England | ||
Green Biologics | $21M | 02 Dec 2013 | England |
